3

PRIMARY DOCUMENT

Company: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Filed: May 10, 2011
Period of Report: May 2, 2011
Accession Number: 0001250853-11-000036

View Document ↗ View on SEC.gov ↗